ArticleClinical ophthalmology (Auckland, N.Z.)2021

Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab.

Davide Allegrini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.